In vitro phase I metabolism of selective estrogen receptor modulators in horse using ultra-high performance liquid chromatography-high resolution mass spectrometry.
Abstract: Selective estrogen receptor modulators (SERMs) are chemicals that possess the anti-oestrogenic activities that are banned 'in' and 'out' of competition by the World Anti-Doping Agency (WADA) in human sports, and by the International Federation of Horseracing Authorities (IFHA) in horseracing. SERMs can be used as performance-enhancing drugs to boost the level of androgens or to compensate for the adverse effects as a result of extensive use of androgenic anabolic steroids (AASs). SERMs have indeed been abused in human sports; hence, a similar threat can be envisaged in horseracing. Numerous analytical findings attributed to the use of SERMs have been reported by WADA-accredited laboratories, including 42 cases of tamoxifen and 2 cases of toremifene in 2014. This paper describes the identification of the in vitro phase I metabolites of tamoxifen and toremifene using ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC-HRMS), with an aim to identify potential screening targets for doping control in equine sports. A total of 13 and 11 in vitro metabolites have been identified for tamoxifen and toremifene, respectively, after incubation with homogenized horse liver. The more prominent in vitro biotransformation pathways include N-desmethylation, hydroxylation, and carboxylation. In addition, this is the first report of some novel metabolites for both tamoxifen and toremifene with hydroxylation occurring at the N-methyl moiety. To our knowledge, this is the first study of the phase I metabolism of tamoxifen and toremifene in horses using homogenized horse liver. Copyright © 2017 John Wiley & Sons, Ltd.
Copyright © 2017 John Wiley & Sons, Ltd.
Publication Date: 2017-02-16 PubMed ID: 28054434DOI: 10.1002/dta.2158Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research explores the in vitro phase I metabolism of selective estrogen receptor modulators (SERMs) in horses, to identify possible detection targets for doping control in equine sports. It utilizes ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC-HRMS) for this purpose.
About Selective Estrogen Receptor Modulators (SERMs)
- SERMs are chemicals exhibiting anti-oestrogenic activities.
- The World Anti-Doping Agency (WADA) in human sports and the International Federation of Horseracing Authorities (IFHA) in horseracing, have banned their use in and out of competition.
- They can be used as performance-enhancing drugs to increase androgen levels or to counteract the adverse effects resulting from extensive use of androgenic anabolic steroids (AASs).
- There’s a history of SERMs being misused in human sports, a threat which also looms over horseracing.
Results from Analytical Findings
- Several analytical findings, including 42 cases of tamoxifen and 2 cases of toremifene in 2014, have been reported by WADA-accredited laboratories, implicating the usage of SERMs.
- In this research, 13 and 11 in vitro metabolites have been identified for tamoxifen and toremifene, respectively, after incubation with homogenized horse liver, using UHPLC-HRMS.
- N-desmethylation, hydroxylation, and carboxylation have emerged as the more dominant in vitro biotransformation pathways.
- The research also reported, for the first time, some novel metabolites for tamoxifen and toremifene, with hydroxylation occurring at the N-methyl group.
Significance and Novelty of the Study
- This is the first study of in vitro phase I metabolism of tamoxifen and toremifene in horses using homogenized horse liver.
- The findings could serve as potential screening targets for equine sports doping control, thereby helping to better regulate the use of performance-enhancing substances in horseracing.
Cite This Article
APA
Kwok KY, Chan GHM, Kwok WH, Wong JKY, Wan TSM.
(2017).
In vitro phase I metabolism of selective estrogen receptor modulators in horse using ultra-high performance liquid chromatography-high resolution mass spectrometry.
Drug Test Anal, 9(9), 1349-1362.
https://doi.org/10.1002/dta.2158 Publication
Researcher Affiliations
- Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T., Hong Kong, China.
- Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T., Hong Kong, China.
- Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T., Hong Kong, China.
- Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T., Hong Kong, China.
- Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T., Hong Kong, China.
MeSH Terms
- Anabolic Agents / analysis
- Anabolic Agents / chemistry
- Androgens / analysis
- Androgens / chemistry
- Animals
- Chromatography, High Pressure Liquid
- Horses
- Humans
- Hydroxylation
- Selective Estrogen Receptor Modulators / chemistry
- Selective Estrogen Receptor Modulators / metabolism
- Tandem Mass Spectrometry
- Toremifene / analysis
- Toremifene / chemistry
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists